Healio June 09, 2023 Robert Herpen Read the full article>> Key takeaways: A machine learning model processed data from more than 32,000 records, 96,000 encounters of those with MDD. Application of the model created an exponential amount of PHQ-9 scores and patient records. MIAMI BEACH, Fla. — A novel machine learning model accurately estimated scores[…]
Dermatology Times Jun 6, 2023 Stefan Weiss, MD, MHSc, MBA Kaitlyn Bader, Senior Editor Watch the video >> OM1 is a large-scale data analytics company with a dedication to improving health outcomes through targeted research. Dermatology Times® recently spoke with Stefan Weiss, MD, MHSc, MBA, a board-certified dermatologist and the managing director of dermatology at OM1, to discuss the[…]
Register to watch>> Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data. Extracting as much information as possible from real-world datasets is essential for understanding the complete patient journey. Subtle patterns in[…]
Business Wire May 24, 2023 Read the full press release>> OM1 now offers a complementary suite of easy-to-digest analytics that give a real-world, 360° view of trends in treatment behaviors and patient outcomes May 24, 2023 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, outcomes, and technology company with a focus on chronic[…]
Psychiatric Times May 21, 2023 Carl D. Marci, MD Steven P. Levine, MD Watch the video>> Carl D. Marci, MD, and Steven P. Levine, MD, caught up with Psychiatric Times in this exclusive video after their session, “Treatment Resistant Depression From Multiple Perspectives: Does It Exist?“ Learn more about 3 potential definitions of treatment resistant depression and[…]
